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Respiratory infections are an acute challenge   
in critical care medicine, typically affecting the 
very old, very young, and chronically ill. The 
Center for Disease Control and Prevention es-
timates that, in the United States, 1.7 million 
hospital-acquired respiratory infections claim 
90,000 lives every year. This mortality rate is rising 
due to an increased number of immunosup-
pressed patients, exposure to drug-resistant organ-
isms, and a growing elderly population (Mizgerd, 
2008; Esperatti et al., 2010; Magret et al., 2011; 
Venkatachalam et al., 2011). There is, therefore, an 
urgent need to find novel therapeutic targets, and 
to do so requires deeper understanding of the dis-
ease’s underlying pathophysiology.
Vertebrate animals rely on their diverse leuko-
cyte populations to recognize and clear patho-
gens that breach mucosal barriers (Medzhitov, 
2007). Infection of the lung mobilizes lympho-
cytes, granulocytes, and mononuclear phago-
cytes. Among the lymphocytes, the innate-like 
B1 B cells reside predominantly in serosal cavi-
ties. In response to infection, serosal B1 B cells 
relocate from either the pleural space or perito-
neum and accumulate in either lung-draining 
lymph nodes or the spleen, respectively (Kawahara 
et al., 2003; Ha et al., 2006; Yang et al., 2007; 
Choi and Baumgarth, 2008; Moon et al., 2012). 
B1 cells are major producers of natural IgM   
antibodies that protect the host by opsonizing 
pathogens and promoting complement receptor–
mediated  phagocytosis  (Boes  et  al.,  1998; 
Baumgarth et al., 2000; Ansel et al., 2002; Fabrizio 
et al., 2007; Choi and Baumgarth, 2008; Racine 
and Winslow,  2009;  Ehrenstein  and  Notley, 
2010; Baumgarth, 2011; Litvack et al., 2011; 
Schwartz et al., 2012), but the mechanisms con-
trolling B cell activation, as well as the conse-
quences of relocating from serosal sites, are not 
fully known. We have recently shown in an ab-
dominal sepsis model that peritoneal B1a B 
cells (a subset of B1 B cells) give rise to a popu-
lation of B cells called innate response activator 
(IRA) B cells that produce the growth factor 
GM-CSF (Rauch et al., 2012). IRA B cells   
arise in the mouse by recognizing microbes via 
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Pneumonia is a major cause of mortality worldwide and a serious problem in critical care 
medicine, but the immunophysiological processes that confer either protection or morbidity 
are not completely understood. We show that in response to lung infection, B1a B cells 
migrate from the pleural space to the lung parenchyma to secrete polyreactive emergency 
immunoglobulin M (IgM). The process requires innate response activator (IRA) B cells, a 
transitional B1a-derived inflammatory subset which controls IgM production via autocrine 
granulocyte/macrophage colony-stimulating factor (GM-CSF) signaling. The strategic 
location of these cells, coupled with the capacity to produce GM-CSF–dependent IgM, 
ensures effective early frontline defense against bacteria invading the lungs. The study 
describes a previously unrecognized GM-CSF-IgM axis and positions IRA B cells as orches-
trators of protective IgM immunity.
© 2014 Weber et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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induce immunoglobulin secretion (Snapper et al., 1995). 
IgM and GM-CSF co-expression by the same cell prompted 
us to test for a direct link between the antibody and the 
growth factor. We sorted B1a B cells from serosal cavities 
(peritoneal and pleural), locations known to contain B1a B cells. 
After in vitro LPS stimulation, B1a B cells gave rise to GM-
CSF–producing IRA B cells, defined as CD19+ IgMhigh 
CD43+ CD5+ CD138+ CD93+ MHCII+ (Fig. 1 A). B1a B 
cells also expressed the common  chain high-affinity recep-
tor for GM-CSF (Csf2rb, also known as CD131) at high lev-
els  (Fig.  1  B),  which  corresponded  with  transcriptional 
profiling data obtained by the Immunological Genome Proj-
ect (ImmGen) and suggested that B cell–derived GM-CSF 
might be acting in an autocrine manner to produce IgM. To 
test this, we placed sorted B1a B cells from WT, Csf2/  
(i.e., GM-CSF–deficient), and Csf2rb/ mice into culture 
and used flow cytometry to detect intracellular IgM reser-
voirs (Fig. 2, A and B). In response to LPS, WT but neither 
Csf2/ nor Csf2rb/ B1a B cells gave rise to a large popula-
tion of IgM-producing cells (Fig. 1, C and D). GM-CSF was 
necessary but not sufficient to elicit robust IgM production 
because adding GM-CSF to WT cells in medium had no 
TLR4 in the peritoneum and accumulate in large numbers in 
the splenic red pulp. The mechanisms by which B cell–derived 
GM-CSF protects against sepsis, however, are not known.
In this study, we show that in response to microbial airway 
infection, pleural B1a B cells relocate to the lung where they 
produce protective IgM. The process requires IRA B cells; 
animals with a B cell–restricted GM-CSF deficiency fail to 
secrete abundant IgM and consequently succumb to pneu-
monia. Mechanistically, autocrine GM-CSF activates B cells 
for IgM production via the common  chain receptor CD131. 
The study therefore identifies a GM-CSF-IgM activation axis 
that is critical in the response to infection and reveals the 
pleural space as a source of innate-like B cells that infiltrate 
the lung in response to bacterial lung infection.
RESULTS
GM-CSF controls IgM production
IgM production is a defining feature of innate-like B cells 
(Ehrenstein and Notley, 2010; Baumgarth, 2011; Cerutti et al., 
2013). We have previously shown that IRA B cells are B1a-
derived GM-CSF and IgM-producing cells (Rauch et al., 
2012), whereas others have documented that GM-CSF can 
Figure 1.  GM-CSF controls IgM produc-
tion. (A) In vitro culture of CD19+ serosal  
B cells. Gating strategy and phenotyping of IRA 
B cells 2 d after culture in medium or with  
10 µg/ml LPS. A representative contour plot of 
n > 5 is shown. (B) CD131 (Csf2rb) expression on 
selected cells from WT mice (n = 4). (C) In vitro 
culture of serosal B1a cells sorted from WT, 
Csf2/, and Csfrb/ mice. Data show intra-
cellular IgM and GM-CSF in cells cultured in 
medium alone or after LPS (10 µg/ml) stimula-
tion after 1 d of culture (n = 3–5). The gate for 
GM-CSF was set using an isotype control (IgG2a) 
and the gate for intracellular IgM represents the 
upper 99% limit of intracellular IgM staining at 
baseline. (D) In vitro culture of serosal B1a cells 
sorted from WT, Csf2/, and Csfrb/ mice, 
and B2 cells sorted from WT mice. Percentage 
of IgM(ic)high cells cultured for 1 d in medium, 
after stimulation with 10 µg/ml LPS alone, or  
10 µg/ml LPS + rGM-CSF, or with a Stat5 in-
hibitor (n = 3–8, mean ± SD). ns, not significant.   
(E) IgM ELISA of culture supernatants from the 
same groups as in D (n = 3–8, mean ± SD).  
ns, not significant. (F) IgM ELISPOT of cultured 
B1a cells. A representative ELISPOT of n = 3 is 
shown. (G) Quantitative RT-PCR analysis of Csf2 
and Prdm1 expression in cultured serosal  
B1a cells from WT, Csf2/, and Csf2rb/ mice 
with and without LPS (10 µg/ml) stimulation for 
1 d (n = 3). Csf2 expression levels after LPS 
stimulation is shown relative to WT LPS as 
mean ± SD. Prdm1 expression after LPS stimu-
lation is shown relative to WT medium as  
mean ± SD (nd, not detected). *, P < 0.05;  
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001.JEM Vol. 211, No. 6 
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2007; Nutt et al., 2007). In sum, the data show that B1a-
derived IRA B cell secretion of GM-CSF promotes IgM 
production via CD131. This is a previously unrecognized GM- 
CSF-IgM axis that may be central to the early response to 
bacterial infection.
Protection against pneumonia requires pleural IRA B cells
The in vitro generation of IRA B cells from serosal B1a   
B cells led us to test whether IRA B cells can arise in the air-
ways in vivo. We delivered LPS intranasally (i.n.) to WT mice 
and profiled the appearance of IRA B cells in various com-
partments 1 and 2 d later. Absolute IRA B cell numbers were 
highest in the lung and pleural space 2 d after LPS injection, 
with small numbers of IRA B cells accumulating in the bron-
choalveolar lavage (BAL) and negligible numbers accumulat-
ing in both the lung-draining LN and blood at any point in 
time (Fig. 3, A and B). Expressing the increase of IRA B cells 
as a percentage of total B cells revealed dramatic increases in 
the pleural space, lung, and BAL (Fig. 3 C).
To determine whether IRA B cells are important in the 
host response to airway infection, we generated mixed chi-
meric mice with a B cell–restricted GM-CSF deficiency (Fig. 4). 
The procedure involved lethal irradiation of WT mice and   
reconstitution with a mixture of bone marrow cells from 
effect. Adding  recombinant  (r)  GM-CSF  to  Csf2/  B1a   
cell cultures partially restored, whereas adding rGM-CSF to 
WT B1a cells augmented IgM production (Fig. 1 D). Al-
though the rescue effect was partial in absolute values, the 
10-fold increase of IgM by Csf2/ cells after rGM-CSF 
was similar to that observed in WT cells. These data suggest 
that despite GM-CSF’s absence during B1 cell development 
in Csf2/ mice, which might affect the cells’ ability to re-
spond to LPS, a relatively robust response nevertheless occurs, 
providing evidence that GM-CSF stimulates IgM production. 
To illustrate the link between GM-CSF and IgM in WT cells, 
we focused on Stat5, which is crucial in the GM-CSF signal-
ing pathway (Mui et al., 1995). Adding a Stat5 inhibitor to 
B1a cell cultures abrogated IgM production. B2 cells cultured 
with LPS likewise produced IgM, albeit at much lower levels. 
The  intracellular  IgM  reservoirs  correlated  with  secreted 
IgM, as measured by ELISA (Fig. 1 E) and ELISPOT (Fig. 1 F). 
RT-PCR confirmed that WT and Csf2rb/ but not Csf2/ 
cells produced GM-CSF in response to LPS (Fig. 1 G). When 
compared with Csf2/ and Csf2rb/ B1a B cells, stimulated 
WT B1a B cells expressed moderately higher levels of Prdm1 
(Fig. 1 H), the gene which codes for Blimp-1, which is an essen-
tial transcription factor in plasma cell generation (Shapiro-
Shelef et al., 2003; Savitsky and Calame, 2006; Fairfax et al., 
Figure 2.  Intracellular staining of IgM. (A) Serosal B1a cells 
were sorted, placed in culture with LPS for 1 d, and stained for 
surface and intracellular IgM. Data show that the procedure can 
stain for intracellular IgM and that both surface and intracellular 
staining can be resolved. Surface IgM staining is followed by 
intracellular staining. A representative analysis of n > 5 is 
shown. (B) Validation of IgM production by ELISPOT on sorted 
B1a cavity cells 1 d after in vitro LPS stimulation. Shown is a 
representative analysis from n > 5.
Figure 3.  Identification of IRA B cells after airway chal-
lenge. (A) Identification of IRA B cells in the lung 2 d after LPS 
i.n. challenge. A representative dot plot of n > 5 is shown.  
(B) Enumeration of IRA B cells in different organs in steady-state 
and after LPS challenge (n = 4/group). (C) Enumeration as per-
centage increase (n = 4). Relevant data are presented as mean ± 
SD and tested by ANOVA; *, P < 0.05; **, P < 0.01; ***, P < 0.001.1246 IRA B cells in pneumonia | Weber et al.
in the pleural space, blood, and lung in the steady-state   
were most similar between the GM/µMT and WT/µMT 
chimeras (Fig. 4 A), but all three chimeras developed various 
B cell subsets (Baumgarth, 2011), including B1a B cells, as 
expected (Düber et al., 2009; Esplin et al., 2009; Holodick   
et  al.,  2009).  Even  though  reconstitution  was  sub-optimal 
compared with non-irradiated WT mice (Fig. 4, B–D), the 
chimeras’ leukocytes were of donor origin (Fig. 4 E), and the 
mice had normal lung histology (Fig. 4 F) without evidence of   
alveolar proteinosis (Fig. 4, G and H). Complete GM-CSF 
deficiency leads to the development of spontaneous alveolar 
proteinosis (Dranoff et al., 1994; Stanley et al., 1994). Previous 
data have shown (Huffman et al., 1996), and our data con-
firm,  that  pulmonary  epithelial  (i.e.,  nonhematopoietic)   
GM-CSF–producing cells prevent proteinosis by stimulating 
alveolar macrophages to clear surfactant; B cells are dispens-
able in this context.
µMT and GM-CSF–deficient mice. Accordingly, the µMT 
bone marrow gave rise to GM-CSF–sufficient leukocytes, 
but not B cells, whereas the GM-CSF–deficient bone mar-
row gave rise to GM-CSF–deficient leukocytes, including   
B cells. After 10 wk of reconstitution, all B cells (which   
necessarily derived from GM-CSF–deficient mice) lacked 
the capacity to produce GM-CSF in the mixed chimeras 
(GM/µMT). The remaining leukocytes were a mixture of 
WT and GM-CSF–deficient cells, whereas radiation-resistant 
and tissue-resident nonhematopoietic cells were GM-CSF–
sufficient. We also generated two types of controls: WT mice 
reconstituted with a mixture of WT and µMT bone marrow 
cells (WT/µMT), which controlled for the µMT contribu-
tion, and WT mice reconstituted with a mixture of GM-
CSF–deficient and WT bone marrow cells (GM/WT), which 
controlled for the contribution of any GM-CSF–deficient   
non–B cells in the GM/µMT group. The leukocyte profiles 
Figure 4.  Generation of mixed chimeras. (A) Leukocyte reconstitution in WT/µMT, GM/WT, and GM/µMT mice in the pleural space, blood, and lung 10 wk 
after irradiation and bone marrow transfer. Data show the relative percentages of myeloid (CD11b+) and nonmyeloid (CD11b) cells in the three compart-
ments (n = 4, mean ± SD). (B) B cells in the pleural space of a WT mouse. Gating strategy for B1a (CD19+IgMhighCD43+CD5+), B1b (CD19+IgMhighCD43+CD5), 
B2 (CD19+IgMlowCD43CD5), and B reg (CD19+IgM+CD43CD5+) B cells is shown. (C) Relative proportions of total B cells and B1a B cells in the pleural space 
of WT/µMT, GM/WT, and GM/µMT chimeric mice and non-irradiated WT mice in the steady state. The chimeric mice were analyzed 8 wk after bone marrow 
transfer (n = 3–5, mean ± SD). (D) Enumeration of the various subsets in the three chimeras (n = 3–5, mean ± SD). (E) CD45.2 expression on blood leukocytes in 
CD45.1+ mice that had been lethally irradiated and reconstituted with CD45.2+ bone marrow cells 10 wk earlier. The plot is representative from that of the three 
chimeras. (F) Lung H&E in the three sets of chimeric mice 10 wk after bone marrow reconstitution (bars, 200 µm). (G) Turbidity analysis of BAL at 600 nm from 
WT/µMT, GM/µMT, WTGM (lethal irradiation of WT mouse and 100% reconstitution with Csf2/ BM), and GMWT (lethal irradiation of Csf2/ mouse and 100% 
reconstitution with WT BM) chimera (n = 3; mean ± SD). (H) BAL of WT/µMT, GM/WT, GM/µMT, WTGM, and GMWT chimeric mice.JEM Vol. 211, No. 6 
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WT/µMT mice indicated that IRA B cells are dispensable to 
steady-state IgM production. After infection, control but not 
GM/µMT mice showed augmented IgM in the pleural space, 
lung, and serum, indicating impaired emergency IgM pro-
duction in mice lacking IRA B cells (Fig. 6 A). Immunofluor-
escence microscopy showed lung B cells in GM/µMT mice 
to be weakly positive for IgM compared with controls (Fig. 6 B). 
The data suggest that B cell–derived GM-CSF is required for 
IgM production in vivo in response to lung infection.
Given GM-CSF’s reported role in emergency hematopoi-
esis (Zhan et al., 1998), we also tested whether the absence of 
B cell–derived GM-CSF impaired the generation of monocy-
tosis and granulopoiesis. Surprisingly, the GM/µMT chimeras 
generated more, not fewer, myeloid cells. Compared with WT/
µMT controls, GM/µMT mice had higher numbers of neu-
trophils in the lungs, blood, and bronchoalveolar lavage (BAL) 
fluid (Fig. 6, C and D). Interestingly, neutrophils in GM/µMT 
mice phagocytosed bacteria poorly (Fig. 6 E), possibly reflect-
ing insufficiency of IgM, an isotype known to facilitate com-
plement  receptor–mediated  phagocytosis  (Baumgarth,  2011; 
Schwartz et al., 2012). Finally, GM/µMT mice expressed higher 
levels of the inflammatory mediators IL-1, IL-6, TNF, and 
CXCL1 in the BAL (Fig. 6 F). We did not detect IL-10 in the 
groups, which argues against a B regulatory phenotype in this 
model. Thus, impaired IgM production, rather than impaired 
myelopoiesis, appeared to contribute to infection susceptibility 
in animals lacking B cell–derived GM-CSF.
Pleural B1a B cells migrate to the lung parenchyma
Coelomate animals contain peritoneal, pleural, and peri-
cardial cavities that shield and support internal organs. The 
pleural cavity is the space between the outer parietal pleura 
attached to the chest wall and the inner visceral pleura that 
covers the lungs. Its primary purpose may be to aid lung func-
tion, as the pleural fluid allows the membranes to slide effort-
lessly during ventilation, but the space also contains immune 
cells such as macrophages and B cells. Such leukocyte location 
could be strategic; pleural cells may function as either senti-
nels against barrier-breaching or reservoirs for lung infiltration.   
Our observations that serosal B1a B cells can give rise to IRA 
B cells in vitro (Fig. 1 A); that IRA B cells arise in the pleural 
space/lung during airway infection (Fig. 3); and that B cell–
derived GM-CSF controls IgM production in the airways 
After reconstitution, we infected GM/µMT, WT/µMT, 
and GM/WT mice with Escherichia coli. Although E. coli are 
not the predominant pneumonia-causing pathogen, they are 
Gram-negative, LPS-bearing bacteria and are responsible for 
a significant proportion of hospital-acquired pneumonias 
(Williams et al., 2002; Klevens et al., 2007; Scott et al., 2008; 
Esperatti  et  al.,  2010;  Jones,  2010;  Magret  et  al.,  2011;   
Venkatachalam et al., 2011). We monitored infected mice for 
morbidity and bacterial titer. As additional controls, we in-
fected WT, B cell–deficient µMT mice (i.e., nonirradiated, 
nonchimeric), and WT mice that received anti-CD116 in-
trapleurally (i.e., anti–GM-CSFR, the subunit of the GM-
CSF receptor which is specific to GM-CSF; the antibody has 
been reported to be neutralizing). Three groups of mice—
µMT, WT receiving anti-CD116, and chimeric GM/µMT 
(i.e., IRA KO)—became very morbid (Fig. 5 A), hypothermic 
(Fig. 5 B), and had increased bacterial counts in the BAL   
(Fig. 5 C). In contrast, WT mice and the two chimeric con-
trols were more resistant to infection. The data show that   
B cell–derived GM-CSF is important and beneficial to the 
early response to airway infection. The similarity between 
µMT and GM/µMT mice in failing to protect against infec-
tion illustrates that GM-CSF production by B cells is an es-
sential component of the overall B cell response at this early 
time point. Blocking CD116, GM-CSF’s specific receptor 
subunit, confirmed that GM-CSF signaling is important in 
WT mice in vivo. We also wondered whether the key finding 
that IRA B cells are protective was specific to E. coli or might 
also apply to other bacterial pathogens. GM/µMT mice in-
fected with Streptococcus pneumoniae, a major cause of disease 
in humans worldwide and the primary pathogen responsible 
for pneumonia (Mizgerd, 2008), died earlier and in larger num-
bers than controls (Fig. 5 D). These data underscore the im-
portance of IRA B cells in pneumonia, thereby prompting us 
to delve further into these protective processes.
Impaired IgM production in the absence of IRA B cells
Having  observed  that  B  cell–derived  GM-CSF  protected 
against pneumonia, we next examined the mixed chimeras’ 
cellular and humoral response, particularly whether the ab-
sence of B cell–derived GM-CSF associates with impaired 
IgM production in vivo. In the steady-state, IgM was readily 
detectable, and its similar concentrations in GM/µMT and 
Figure 5.  IRA B cells protect against pneumo-
nia. (A) Clinical score of WT, WT receiving anti-
CD116, µMT, WT/µMT, GM/WT, and GM/µMT mice 9 h 
after infection with E. coli (n = 5–10 mice). (B) Body 
temperature of the groups above. (C) Bacterial titer in 
BAL after E. coli infection of WT, WT receiving anti-
CD116, µMT, WT/µMT, GM/WT, and GM/µMT mice  
(n = 5–10 mice). (D) Kaplan-Meier survival curves  
after S. pneumoniae i.t. infection for WT/µMT, GM/WT, 
and GM/µMT mice (n = 8–10). Relevant data are pre-
sented as mean ± SD and tested by ANOVA; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.1248 IRA B cells in pneumonia | Weber et al.
the lung from the peritoneum, and only a small number of 
cells accumulated in the spleen from either source (Fig. 7 E). 
To focus on pleural B1a B cells specifically, we adoptively 
transferred sorted pleural GFP+ B1a B cells to the pleural 
space. After 2 d of LPS challenge, a substantial fraction (26%) 
of all B1a cells in the lung were GFP+ (Fig. 7 F), and the   
cells were readily visible by fluorescence microscopy (Fig. 7 G). 
The pleural space, but not the blood, still contained many 
GFP+ B1a B cells at this time point (Fig. 7 F), which sug-
gested that pleural B1a cells relocated directly from the pleu-
ral space to the lungs. Indeed, pleural cells were readily observed 
in regions close to the mesothelial layer, the single-cell barrier 
known to express adhesion molecules—such as VCAM-1 
(Jonjić et al., 1992)—that separates lung tissue from the pleu-
ral space.
Pleural B1a B cells produce protective IgM in the lungs
The leukocyte profile and the differences between the two de-
livery routes suggested that the pleural space was the preferential 
(Fig. 6, A–C) prompted the hypothesis that the pleural space 
sources lung-infiltrating IgM-producing B cells in response to 
bacterial airway infection. To test this, we developed the   
intercostal approach of the pleural space (ICAPS) method 
(Fig. 7 A), in which a catheter is intercostally inserted into the 
organism’s thorax at a low angle to bypass the diaphragm and 
reduce the risk of puncturing the lung. When the catheter is 
removed, the intercostal muscles seal the puncture canal and 
prevent a pneumothorax. We confirmed the validity of this 
procedure by injecting a CT imaging contrast agent into the 
pleural space (Fig. 7 B) and transferring GFP+ leukocytes for 
in vivo fate mapping (Fig. 7 C).
To track leukocyte migration, we transferred total pleural 
and peritoneal GFP+ cells to either the pleural or peritoneal 
space of mice receiving LPS. 2 d after transfer, we enumerated 
GFP+ cells that had accumulated in various organs. Cells 
transferred to the pleural space accumulated in the lung prefer-
entially and were enriched for B cells (Fig. 7, D and E). In 
contrast, only a small number of GFP+ cells accumulated in 
Figure 6.  Enhanced inflammation but attenuated IgM after E. coli airway infection in the absence of IRA B cells. (A) IgM levels detected by 
ELISA in serum, BAL, and pleural space 9 h after E. coli infection (n = 6–10 mice). (B) Lung histology after E. coli infection. DAPI: blue; CD19: red; IgM: 
green; merge: yellow. Representative pictographs of n = 6–10 animals/group are shown (bars: overview, 100 µm; inset, 10 µm). Arrows indicate 
IgM+CD19+ cells. (C) Analysis of WT/µMT and GM/µMT mice after i.t. E. coli infection. Immunohistochemical staining for neutrophils in lung tissue and 
enumeration of neutrophils measured by counts of neutrophils per field of view. A representative slide of n = 6–10 is shown (bars, 400 µm). (D) Enumera-
tion of neutrophils in blood and BAL (n = 6–10). (E) Analysis of the phagocytic capacity of neutrophils from the BAL of WT/µMT and GM/µMT mice. Shown 
are total cell numbers with phagocytosed Pkh26+ bacteria (n = 4). (F) Analysis of BAL levels for IL-1, IL-6, TNF, and CXCL1 (n = 5–15 mice). Relevant data 
are presented as mean ± SD; *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM Vol. 211, No. 6 
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Figure 7.  The pleural space is a reservoir of lung-infiltrating B1a B cells. (A) Cartoon depicting the ICAPS model. After skin incision, a small cath-
eter can be navigated through the intercostal space and placed in the pleural space. (B) Preoperative: (i and ii) CT scans before insertion of the catheter. 
Intraoperative: (iii and iv) CT scans immediately after insertion of the catheter. (v and vi) CT scans after injection of 300 µl Iopamidol iodine CT contrast 
agent. Postoperative: (vii and viii) CT scans 10 min after the catheter was removed. There were no signs of injection into lung parenchyma, pneumotho-
rax, or leakage (top row of CT scans: axial view; bottom rows of CT scans: sagittal view; arrows denote the tip of the catheter; stars donate the injected 
Iopamidol iodine CT contrast agent). (C) Intrapleural (i.e., by ICAPS) transfer of GFP+ serosal cells. Cells were transferred into WT mice which were sacri-
ficed 10 min after transfer. Data show transferred cells in the pleural space, BAL, blood, lung, bone marrow, and spleen. (D) Unsorted GFP+ serosal cells 
were adoptively transferred to the pleural or peritoneal spaces of WT mice that received pulmonary LPS challenge. Data show profile of lung accumula-
tion in recipients 2 d after transfer. A representative experiment of n = 5 is shown. (E) Enumeration of CD19+ and CD19 cells accumulating in the lung 
and spleen after intrapleural or intraperitoneal transfer of unsorted GFP+ serosal cells. A representative enumeration of n = 5 is shown. (F) Intrapleural 
adoptive transfer of serosal B1a GFP+ cells. Data show frequency of adoptively transferred (GFP+) cells in the lung, pleural space, and blood 2 d after pul-
monary LPS challenge. A representative dot plot from n = 4 is shown. (G) Fluorescence microscopy of lung tissue 2 d after intrapleural adoptive transfer 
of sorted GFP+ serosal B1a cells (bars: overview, 20 µm; inset, 10 µm).
source of lung-accumulating serosal B cells. B1a B cells re-
trieved from the lung contained large reservoirs of IgM (Fig. 8, 
A  and  B),  which  they  secreted  locally,  as  measured  by 
ELISPOT assays performed on GFP+ cells that had relocated 
from the pleural space to lung tissue (Fig. 8 C). To determine 
the importance of pleural B cells to the host response, we 
profiled mortality in WT and µMT (i.e., B cell–deficient) 
mice infected with a high dose of E. coli. After 48 h, 40% of WT 
mice died but 60% completely recovered. In contrast, 80% 
of B cell–deficient µMT mice died within 12 h (Fig. 8 D). 1250 IRA B cells in pneumonia | Weber et al.
Moreover, IgM titers were increased in the BAL and pleural 
space of µMT mice receiving WT pleural B cells but not 
Csf2/ pleural B cells (Fig. 8 G). These data indicate that   
in response to airway infection, pleural B cells relocate to   
the lung and produce opsonizing, polyreactive, GM-CSF– 
dependent IgM.
Secreted IgM is necessary for protection against pneumonia
At this point, the data can be summarized as follows: in re-
sponse to pulmonary infection, IRA B cells arise in the pleu-
ral space and lung; in the absence of IRA B cells (absence of 
B cell–derived GM-CSF), mice fail to produce IgM and suc-
cumb to pneumonia; and pulmonary infection mobilizes 
pleural B1a B cells, which relocate to the lung and produce 
IgM. To further validate these findings, we wished to test the 
importance of pleural B cell–derived GM-CSF and secreted 
IgM in our model. We pursued a rescue strategy involving the 
adoptive transfer of different cell populations to the pleural 
spaces  of  GM/µMT  mice. We  transferred  Csf2/  pleural   
B cells, WT pleural non–B cells, pleural B cells from secretory 
IgM-deficient (sIgM/) mice, and WT pleural B cells (Fig. 9 A). 
Comparing the adoptive transfer of WT pleural B cells with 
Csf2/ pleural B cells and WT pleural non–B cells allowed 
us to determine the importance of B cell–derived GM-CSF, 
whereas sIgM/ mice demonstrated the importance of se-
creted IgM. Mice that received WT pleural B cells into the 
Additionally, we used ICAPS to transfer pleural B cells from 
WT mice to the pleural spaces of µMT mice. The µMT pleu-
ral B cell recipients, which now contained B cells but only   
in the pleural space, were then infected with E. coli. Remark-
ably, this B cell supplementation completely reversed the se-
vere mortality otherwise observed in µMT mice (Fig. 8 D). 
For controls, we transferred pleural B cells from Csf2/ mice 
to the pleural spaces of µMT mice and B cells sorted from the 
blood of WT mice to the blood (by i.v.) of µMT mice. Neither 
approach  rescued  the  µMT  mice,  indicating  that  GM-CSF 
produced by pleural B cells was required for protection. The 
data show that pleural B cells defend against pneumonia.
IgM is one of the first antibody isotypes secreted during 
infection. IgM recognizes multiple epitopes with low affinity 
and is therefore polyreactive and innate-like, but its penta-
meric structure increases avidity and allows for potent opsoniz-
ing and complement-fixing functions. To determine whether 
IgM recognized bacteria in our model, we infected µMT 
mice and µMT mice that received pleural B cells into the 
pleural space (Fig. 8 E) with Pkh26-labeled E. coli. 6 h later, 
the BAL fluid contained labeled bacteria in both groups, but 
only bacteria in µMT animals receiving pleural B cells were 
opsonized with IgM (Fig. 8 E). Newly produced IgM (i.e., IgM 
retrieved from the BAL 6 h after LPS intratracheal [i.t.] delivery) 
recognized gram-positive Staphylococcus aureus and gram-negative 
Pseudomonas  aeruginosa,  indicating  polyreactivity  (Fig.  8  F). 
Figure 8.  Pleural B1a B cells accumulating in the lung produce opsonizing IgM that is sufficient to confer survival. (A) Intracellular IgM (IgM 
(ic)) reservoirs in steady-state pleural GFP+ B1a cells (left dot plot) and in GFP+ B1a cells that had infiltrated LPS-challenged lungs after intrapleural trans-
fer (right dot plot). The dotted line represents the upper 99% limit of intracellular IgM staining in steady-state cells. Representative analysis from n = 4 is 
shown. (B) Mean fluorescence intensity (MFI) of IgM (ic) from A (n = 4). (C) IgM ELISPOT analysis of cells as in A. Representative analysis from n = 2 ex-
periments is shown. (D) Kaplan-Meier survival curves in response to E. coli infection in WT mice; µMT mice; and µMT mice that received WT pleural B cells 
in the pleural space, Csf2/ pleural cells in the pleural space, and WT blood cells into the blood at the time of infection (n = 10 mice). (E) Opsonization of 
bacteria with IgM. Data show Pkh26-labeled E. coli retrieved from the BAL of either µMT mice or µMT mice spiked with pleural WT B cells in the pleural 
space. Bacteria (i.t.) and cell transfer (i.pls.) were conducted 6 h before BAL. An antibody against IgM shows opsonization of labeled bacteria. A represen-
tative analysis of n = 3 is shown. (F) IgM is polyclonal. WT mice received PBS or LPS. 6 h later, BAL was collected, and capacity of IgM to bind to S. aureus 
and P. aeruginosa was measured. Data show binding relative to a commercially available polyclonal IgM (n = 3). (G) IgM ELISA of pleural fluid and BAL 
after E. coli infection. µMT mice received WT or Csf2/ pleural B1a cells into the pleural space at the time of infection (n = 3). Relevant data are pre-
sented as mean ± SD; *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM Vol. 211, No. 6 
Article
1251
(Fig. 10 D). Although further work is required to elucidate 
the similarities and differences between murine and human IRA 
B cells, these data nevertheless illustrate our current findings’ 
potential translatability. In sum, the production of GM-CSF by 
IRA B cells orchestrates the generation of protective IgM, which 
is critical in the early defense to infection (Fig. 10 E).
DISCUSSION
The innate immune mechanism described here clears bacteria 
and protects against pneumonia. We show that in response 
to infection, pleural B cells relocate to the lung and produce 
abundant natural IgM, which is known to protect against in-
fection (Boes et al., 1998; Baumgarth et al., 2000; Fabrizio   
et al., 2007; Choi and Baumgarth, 2008; Litvack et al., 2011; 
Schwartz et al., 2012). B cell–derived GM-CSF is the auto-
crine instructor required for emergency IgM production. 
Recently identified IRA B cells, which differentiate from B1a 
B cells in the mouse via direct TLR-dependent pathogen rec-
ognition, are key to this process and therefore to early innate 
immune defense.
GM-CSF was identified in the 1960s as a colony stimulator 
of granulocytes and mononuclear cells, though not erythrocytes 
(Bradley and Metcalf, 1966). GM-CSF–deficient mice, which 
were independently generated by two groups in 1994 (Dranoff 
et al., 1994; Stanley et al., 1994), show no striking perturba-
tions of hematopoiesis in the steady state but develop alveolar 
proteinosis. This condition’s human counterpart is character-
ized by elevated anti–GM-CSF autoantibodies (Carey and 
Trapnell, 2010). In the mouse, GM-CSF is produced by 
pulmonary epithelial cells (Huffman et al., 1996), T cells, and 
macrophages  (Hamilton,  2008;  Hamilton  and Achuthan, 
2013). The growth factor promotes the maturation, survival, 
pleural space were healthier, as judged by their clinical scores, 
body temperatures, and bacterial titers (Fig. 9 B). Moreover, 
mice that received WT pleural B cells had increased titers of 
IgM (Fig. 9 B). That none of the other three strategies pro-
tected the animals indicated that B cell–derived GM-CSF is 
essential. To determine whether polyclonal IgM could indeed 
rescue IRA B cell–deficient, GM/µMT chimeras, we injected 
polyclonal IgM i.t. into GM/µMT mice infected with a high 
dose of E. coli. Compared with controls receiving PBS, poly-
IgM recipients were protected (Fig. 9 C).
Previously, we demonstrated that the human spleen con-
tains a population of GM-CSF–producing IRA B-like cells 
(Rauch et al., 2012). To determine whether humans also con-
tain, or can develop, IRA B-like cells in the pleural space, we 
obtained human pleural fluid by thoracentesis, and cultured   
B cells in either medium or a classical human B cell stimula-
tion cocktail containing anti-Ig and IL-2. After 2 d of culture, 
human pleural CD19+ CD20+ IgM+ B cells produced GM-
CSF (Fig. 10, A–C). The GM-CSF producers clustered in a 
single rather than bimodal distribution, suggesting indiscrimi-
nate activation in this in vitro setting. To reveal whether the 
appearance of IRA B-like cells was unique to the pleural 
space, we also cultured B cells from cord and peripheral blood. 
In the cord blood, which contains predominantly naive and 
transitional cells, a large GM-CSF–producing population 
likewise arose (Fig. 10 C). In contrast, culturing peripheral 
blood B cell did not stimulate GM-CSF production (Fig. 10 C), 
a result which supports the concept that IRA B cells arise in 
specific locations. Adding nontoxic doses of anti–GM-CSF, 
anti-CD116, or a STAT5 inhibitor to the culture containing 
pleural cells prevented the appearance of IRA B-like cells, 
further indicating an important role of the GM-CSF pathway 
Figure 9.  IRA B cells and secreted IgM are required for protection against pneumonia. (A) Postsort analysis of sorted WT, sIgM/, Csf2/  
serosal B cells, or WT serosal non–B cells. Representative plots are shown of n > 10. (B) GM/µMT (i.e., IRA B cell KO) mice received intrapleural transfer of 
WT, sIgM/, Csf2/ serosal B cells, and WT non–B cells (n = 6–15 mice). 6 h later, mice were infected i.t. with E. coli. 9 h later, clinical score, body tem-
perature, bacterial titer in the BAL, and IgM in serum were measured. Data are presented as mean ± SD and tested by ANOVA. (C) Kaplan-Meier Survival 
Curve of GM/µMT mice infected with E. coli receiving either PBS or polyclonal IgM i.t. (n = 10). Relevant data are presented as mean ± SD; ***, P < 0.001.1252 IRA B cells in pneumonia | Weber et al.
and proliferation of its target cells; it controls nonlymphoid 
tissue dendritic cell homeostasis (Greter et al., 2012), emer-
gency granulopoiesis (Kimura et al., 2009), iNKT cell differ-
entiation (Bezbradica et al., 2006), sensitization to allergen 
(Stämpfli et al., 1998), and other effects related to immune acti-
vation (Hege et al., 2006; Timmerman et al., 2009; Le et al., 
2010). In vitro, GM-CSF remains a standard for differentiat-
ing bone marrow progenitors to dendritic cells.
The early appearance of a unique GM-CSF–producing   
B cell in sepsis suggests a leukocyte communication hierarchy 
in which IRA B cells educate their client myeloid cells. A major 
finding of this study is therefore unexpected: IRA B cells pro-
duce GM-CSF for themselves. This autocrine function is all 
the more surprising considering its outcome, which is IgM 
production. At the signaling level, this may involve Blimp-1,   
a transcriptional repressor required for the formation of 
immunoglobulin-secreting B1-derived plasma cells (Shapiro-
Shelef et al., 2003; Savitsky and Calame, 2006; Fairfax et al., 
2007;  Nutt  et  al.,  2007)  and  Stat5,  a  transcription  factor 
downstream of GM-CSF signaling (Mui et al., 1995; Kimura 
et al., 2009) which has been recently shown to amplify Blimp-1 
in T cells (Nurieva et al., 2012). Future studies will need to 
elucidate the precise sequence of events that link GM-CSF 
signaling to IgM production. In addition to investigating how 
signals downstream of GM-CSF and LPS integrate, activate 
Stat5 and Blimp-1, and cooperate to produce IgM, additional 
questions remain as to whether and how GM-CSF contrib-
utes to the generation of mature B1 cells. Because pleural   
B cells can also accumulate in the lung-draining lymph nodes 
(Choi and Baumgarth, 2008), future work must determine 
whether IRA B cell–derived GM-CSF elicits other responses, 
such as generating or activating dendritic cells.
Many cytokines have an endocrine function. IL-1, IL-6, 
and TNF, for example, travel in the bloodstream and affect 
tissues at distance from injury or infection. Evidence sug-
gests that GM-CSF’s activity is more spatially restricted. Serum 
levels of GM-CSF tend to be low in steady state and inflam-
mation because of receptor and autoantibody-mediated clear-
ance (Metcalf et al., 1999). GM-CSF’s pleiotropy relies on 
a binary, concentration-dependent switch (Guthridge et al.,   
2006). In this study, we show that B cell–derived GM-CSF 
is necessary for protective IgM responses but dispensable to 
surfactant clearance by alveolar macrophages. The cellular 
source and location of GM-CSF, our data indicate, is impor-
tant and may be particularly relevant during clinical interven-
tion. Indeed, on the basis of GM-CSF’s capacity to augment 
HLA-DR and potentially arm the host for effective immunity, 
clinical trials have explored using recombinant GM-CSF 
for sepsis treatment (LaRosa and Opal, 2012). A few studies 
showed an all-survival benefit, but a meta-analysis found no 
consensus among the trials, and thus no evidence to support 
routine GM-CSF use (Bo et al., 2011). In all trials, however, 
GM-CSF was delivered either intravenously or subcutane-
ously. Future studies will need to determine whether locally 
administering GM-CSF to strategic locations, such as the 
Figure 10.  IRA B cells in humans. (A) Human pleural B cells were 
placed in vitro for 2 d and stimulated with anti-Ig and IL-2. Data show 
the appearance of GM-CSF–producing, IRA-like B cells. (B) Fluorescence-
minus-one (FMO) and isotype controls of stimulated human B cells.  
(C) Total B cells were collected from human pleural space, cord blood, and 
peripheral blood and cultured for 2 d either in medium or with anti-Ig 
and IL-2 stimulation. Data show quantity of IRA-like B cells appearing in 
each condition. (D) Total B cells from the pleural space were cultured as in C, 
and with anti–GM-CSF, anti-CD116, or a Stat5 inhibitor. Data show  
quantity of IRA-like B cells appearing in each condition (n = 4–15). Rel-
evant data are presented as mean ± SD. ***, P < 0.001. (E) Model for the 
function of IRA B cells in mouse pneumonia. During airway infection 
pleural space B1a cells recognize bacteria or its components (1). This leads 
to the generation (2) of IRA B cells which produce GM-CSF and express 
the GM-CSF receptor. GM-CSF acts on its receptor in an autocrine (3) 
manner. The signaling orchestrates generation of IgM-producing cells (4) 
which relocate to the lung (5). IgM derived from pleural space B cells is 
essential to the control of bacteremia (6).JEM Vol. 211, No. 6 
Article
1253
breathing and cyanosis (3); [d] hydration status: normal (0), dehydrated (5). 
The higher the score is, the worse the clinical situation of the animal.
Temperature. The body temperature of each animal was measured by rec-
tal insertion of a temperature sensor while the mouse was under anesthesia.
CD116  (GM-CSF-Ra)  antibody  injection.  200  µg  anti–GM-CSF-R  
(anti-CD116; R&D Systems) was i.pls. injected 2 h before infection with E. coli.
Polyclonal IgM injection. 25 µg in 50 µl polyclonal IgM (Rockland) was 
injected i.t. 3 h after E. coli infection.
Cell injection. Sorted cells, as defined below and in figures, were injected 
i.pls., i.p., and i.v. at time points defined in figures.
Bacteria
Bacterial titer. Bronchoalveolar lavage (BAL) samples were diluted, plated 
on tryptic soy agar (BD), and incubated at 37°C. The number of bacterial 
colonies was assessed 12–14 h later.
Detection of bacterial IgM coating after Pkh26 labeling. E. coli 
were labeled with Pkh26 (Sigma-Aldrich) according to the manufacturer’s 
instructions. After i.t. infection with 5 × 106 CFU labeled E. coli, bacteria 
in the BAL were stained with anti–IgM-APC and anti–CD45.2–Pacific 
blue. For FACS analysis, the flow cytometric FSC and SSC setting was set 
to detect bacteria.
Phagocytosis assay. Phagocytosis was assessed using a pHrodo E. coli BioPar-
ticles Phagocytosis kit (Invitrogen) as instructed by the manufacturer.
Polyclonality assay. High protein binding capacity microtiter plate wells 
(Nunc Maxisorp; Sigma-Aldrich) were coated overnight at 4°C with 107 
CFU of S. aureus or P. aeruginosa. After washing, a 1% BSA blocking solution 
was added to each well for 4 h at room temperature. Wells were washed and 
200 µl BAL obtained 6 h after challenging WT mice with either PBS or LPS 
(E. Coli O55:B5; Sigma-Aldrich) was added to each well for 4 h at room 
temperature. After washing, 200 µl polyclonal anti–IgM–Alexa Fluor 488 
antibodies (Abcam) diluted to 1:200 were added for 1 h at room temperature 
in the dark. Fluorescence was read on a Spectramax M3 plate reader (Molecular 
Devices). Mouse polyclonal IgM (Rockland) diluted to 1:1,000 served as a 
positive control for IgM.
Murine leukocytes
Isolation. Peripheral blood for flow cytometry was collected by aortic punc-
ture, using a 50 mM EDTA solution as anticoagulant. Erythrocytes were lysed 
using RBC Lysis Buffer (BioLegend). Total white blood cell count was ob-
tained by preparing a 1:10 dilution of (undiluted) peripheral blood from the 
orbital sinus using heparin-coated capillary tubes in RBC Lysis Buffer (Bio-
Legend). After organ harvest, single cell suspensions were obtained as follows: 
for bone marrow, the femur and tibia of one leg were flushed with PBS through 
a 40-µm nylon mesh. Spleens and lymph nodes were homogenized through a 
40-µm nylon mesh, after which erythrocyte lysis was performed using RBC 
Lysis Buffer (BioLegend). Lungs and liver were cut into small pieces and sub-
jected to enzymatic digestion with 450 U/ml collagenase I, 125 U/ml collage-
nase XI, 60 U/ml DNase I, and 60 U/ml hyaluronidase (Sigma-Aldrich) for 
1 h at 37°C while shaking. Total viable cell numbers were obtained using Try-
pan Blue (Cellgro; Corning). For selected experiments, the pleural space was 
lavaged with 2 × 1 ml PBS and the peritoneal space was lavaged with 2 × 5 ml 
of PBS to retrieve leukocytes. BAL was performed by flushing the lungs with 
4 × 1 ml PBS to retrieve the infiltrated and resident leukocytes. Single-cell 
suspensions were prepared or cells were MACS-sorted according to the man-
ufacturer’s instructions and as described below.
In vitro culture. Cells were cultured in 96-well round-bottom plates 
(Corning) and kept in a humidified CO2 incubator at 37°C for 24 h. B1a 
cells were cultured in RPMI-1640 supplemented with 10% fetal bovine 
pleural space, can overcome host clearance mechanisms and 
engender a durable clinical benefit.
The adaptive arm of the immune system requires lymphoid 
tissues in which leukocytes interact, proliferate, and, over time, 
generate antigen specificity and memory. For innate immunity 
to be effective, it must respond to a different challenge: it has   
to act quickly. The pleural space’s proximity to the lung gives 
pleural leukocytes an advantage in meeting this challenge. The 
observation that pleural space B cells control the early response 
to infection is significant because it broadens our understand-
ing of the immune system’s spatio-cellular dynamics. Addition-
ally, the mechanistic insight that a particular B cell controls this 
event via a previously unrecognized GM-CSF-IgM axis might 
have important biological and therapeutic implications for the 
treatment of infectious diseases.
MATERIALS AND METHODS
Animals
C57BL/6J (WT), B6.SJL-PtprcaPepcb/BoyJ (CD45.1+), C57BL/6-Tg(UBC-
GFP)30Scha/J (GFP+), and B10.129S2(B6)-Ighmtm1Cgn/J (MT) female 
mice (The Jackson Laboratory) were used in this study. GM-CSF–deficient 
mice (Csf2/) were a gift from R. Seeley (University of Cincinnati, Cin-
cinnati, OH). Secretory IgM-deficient mice (sIgM/) were a gift from   
K. Alugupalli  (Thomas  Jefferson  University,  Philadelphia,  PA).  GM-CSF   
receptor-deficient mice (Csf2rb/) were a gift from J. Whitsett (Cincinnati 
Children’s Hospital Medical Center, Cincinnati, OH). All mice were 8–20 wk 
of age at the time of sacrifice. All protocols were approved by the Animal Re-
view Committee at Massachusetts General Hospital.
Animal models and in vivo interventions
For the adoptive transfer of cells i.v., i.p., or into the pleural space (i.pls.), 
mice were anesthetized with isoflurane.
Intrapleural injection using the ICAPS model. After fixation of the 
mice with tape, a right anterolateral thoracic incision was performed over   
2–3 cm, followed by careful sharp dissection of the attached muscles from the 
thoracic wall. A polyethylene catheter (Intramedic, I.D. 0.28 mm; BD) was 
then tangentially inserted into the pleural space without harming the lung 
parenchyma. Cells, contrast agent, or PBS was injected. After removing the 
catheter, we controlled for pneumothorax and adequate breathing. Skin   
closure was performed with an Ethilon 5/0 suture and pain medication   
(0.1 mg/kg buprenorphine) was injected i.p.
Mixed bone marrow chimeras. Naive WT mice were lethally irradiated 
(10 Gy). 4–7 h after irradiation, animals were reconstituted with a 1:1 mix-
ture of total bone marrow cells from MT, WT, or Csf2/ mice (Rauch   
et al., 2012). A total of 4 × 106 cells were injected intravenously. Animals 
were allowed to recover for a minimum of 8 wk.
Pneumonia models. Animals were infected i.n. or i.t. with 20 µg LPS; 2.5, 5, 
7.5, or 15 × 106 CFU E. coli (American Type Culture Collection); or 2.5 × 104 
S. pneumoniae (American Type Culture Collection) in a volume of 50 µl saline.
Survival. Animals injected i.t. with high doses of bacteria were monitored 
for survival over the course of 10 d.
Clinical score. The clinical score of each animal was assessed blinded as fol-
lows (points in parentheses). [a] appearance: normal (0), lack of grooming (1), 
piloerection (2), hunched up (3), above and eyes half closed (4); [b] behavior - 
unprovoked: normal (0), minor changes (1), less mobile and isolated (2), 
restless or very still (3); behavior - provoked: responsive and alert (0), unre-
sponsive and not alert (3); [c] clinical signs: normal respiratory rate (0), slight 
changes (1), decreased rate with abdominal breathing (2), marked abdominal 1254 IRA B cells in pneumonia | Weber et al.
Intracytoplasmatic  staining  of  IgM.  Isolated  cells  were  stained  for   
30 min with a primary IgM antibody (i.e., APC channel) in a high concen-
tration (1:200) to ensure saturation of surface IgM together with additional 
surface antibodies in normal concentration (1:700). After cell membrane 
permeabilization using the Cytofix/Cytoperm Plus kit (BD), intracytoplas-
matic IgM was performed using the secondary IgM antibody (i.e., PerCP 
channel) in a lower concentration (1:350). Data were acquired on either 
LSRII (BD) or Gallios (Beckman Coulter) flow cytometers and analyzed 
with FlowJo (v8.8.6/v9.7.2; Tree Star). Cells were sorted on a FACSAria II 
(BD) cell sorter.
Histology and imaging
Preparation. The lungs were filled with a mixture of O.C.T. compound 
(Sakura) and PBS (1:1) through trachea before harvesting and embedding in a 
2-methylbutane bath (Sigma-Aldrich) on dry ice. Serial 6-µm fresh-frozen 
sections were prepared and stored at 80°C until immunohistochemical stain-
ing was performed. Lungs from WT/µMT, GM/WT, and GM/MT mice 
were stained with hematoxylin and eosin for overall histological analysis.
Immunohistochemistry. Frozen lung sections were briefly treated with 
0.3% hydrogen peroxidase solution for endogenous peroxidase inactivation. 
The sections were incubated with a neutrophil antibody (NIMP-R14; Santa 
Cruz Biotechnology, Inc.) for 1 h at room temperature, followed by a bio-
tinylated secondary antibody (Vector Laboratories) and an avidin-biotin com-
plex (ABC) kit (Vector Laboratories). AEC (3-amino-9-ethylcarbazole) 
substrate (Dako), which forms a red end-product, was used for the color de-
velopment. All sections were counterstained with Harris hematoxylin solu-
tion (Sigma-Aldrich) and coverslipped using an aqueous mounting medium. 
All the histological images were captured using a digital slide scanner (Nano-
Zoomer 2.0RS; Hamamatsu).
Immunofluorescence  microscopy. The  lung  sections  were  incubated 
with anti-CD19, 1D3 (BD), overnight at 4°C and Alexa Fluor 594 goat anti–
rat IgG (Invitrogen), followed by anti–IgM-FITC, II/41 (BD). The slides 
were coverslipped using a mounting medium with DAPI (Vector Laborato-
ries) to identify the nuclei. Images were captured and processed using an epi-
fluorescence microscope (Eclipse 80i; Nikon Instruments Inc.).
Computed tomography (CT). Mice were imaged with CT using an In-
veon small animal scanner (Siemens). CT images were reconstructed from 
360 cone-beam x-ray projections with a power of 80 keV and 500 A. The 
isotropic resolution of the CT images was 60 µm. Before CT acquisition,   
iodine contrast was infused into the pleural space. The CT acquisition time was 
10 min. Reconstruction of datasets was done using IR W software (Siemens). 
Three-dimensional visualizations were produced using the DICOM viewer 
OsiriX (The OsiriX foundation).
Molecular Biology
ELISA. Human and mouse IgM was measured with an ELISA kit according 
to the manufacturer’s instructions (Bethyl Laboratories, Inc.).
Luminex. Cytokines and chemokines in the bronchoalveolar lavage, 
the pleural space lavage, and serum were measured using a Luminex panel 
from Invitrogen.
ELISPOT. Cells were seeded at a density of 1,000–5,000 cells/100 µl medium. 
The assay (Mabtech) was performed according to the manufacturer’s instructions.
RT-PCR. Total RNA was isolated from 3–10 × 104 FACS-sorted cells 
using the RNeasy Micro kit (QIAGEN) according to the manufacturer’s in-
structions. cDNA was generated using the iScript Select cDNA Synthesis kit 
(Bio-Rad Laboratories). Real-time PCR was performed in duplicates using 
the TaqMan Gene Expression Assay System on a 7300 Real-Time PCR Sys-
tem (Applied Biosystems). Primers for GM-CSF (Csf2; Mm01290062_m1), 
Blimp1  (Prdm1;  Mm00476128_m1),  and  housekeeping  gene  -actin 
serum, 25 mM Hepes, 2 mM l-glutamine, 100 U/ml penicillin, 100 U/ml 
streptomycin, and 50 µM -mercaptoethanol. All cell types were seeded at a 
density of 30,000 cells/100 µl medium. Where indicated, LPS was added at 
10 µg/ml. Stimulation of the cells was performed by adding 0.2 µg/ml rGM-
CSF in PBS. The Stat5 inhibitor (CAS 285986–31-4; Santa Cruz Biotech-
nology, Inc.) was used at 50 µg/ml (i.e., 200 nM).
Human leukocytes
Isolation. As part of a collaboration with the Feinstein Institute, cells were 
separately obtained from fresh peripheral blood samples of human adult 
healthy donors according to IRB-approved protocols (North Shore-LIJ 
Health System), and from fresh umbilical cord blood of anonymous donors 
provided by the Tissue Donation Program at the Feinstein Institute for Medical 
Research. Mononuclear cells from both adult peripheral (PBL) and umbilical 
cord (CB) blood were obtained by density gradient separation using lympho-
cyte separation medium (Cellgro). Cells were also obtained from fresh fluid 
of patients undergoing paracentesis or thoracentesis at Massachusetts General 
Hospital who required the procedure for diverse conditions, most frequently 
cancer. The samples were de-identified for the purposes of this study. The 
centesis involved sterile prepping of the skin and subcutaneous anesthesia of 
tissue with Lidocaine. A small 7 Fr thoracentesis catheter was placed in the 
fluid containing space, allowing removal of the fluid.
In vitro culture. Mononuclear cells (105/200 µl) were plated in medium alone 
(RPMI, 10% fetal calf serum, 2 mM l-glutamine, 10 mM Hepes, 100 U/ml 
penicillin, 100 µg/ml streptomycin, 1 mM sodium pyruvate, and 1× non-
essential amino acids [Life Technologies]), or in medium with 2.5 µg/ml 
goat anti–human IgA + IgG + IgM (Jackson ImmunoResearch Laboratories, 
Inc.) and 10 ng/ml IL-2 (PeproTech) in 96-well U-bottom plates. Blocking 
antibodies were added at 10 µg/ml and STAT5 inhibitor at 50 µg/ml. Cells 
were cultured at 37°C, 5% CO2 for 2 d. 3 h before harvesting, 0.2 µl Golgi-
Plug (BD) was added to the cultured cells to inhibit intracellular protein 
transportation. Cultured cells were then harvested and immunofluorescently 
stained for flow cytometric analysis (see below).
Flow cytometry
The following antibodies were used for flow cytometric analyses. Mouse: anti–
CD43-FITC, S7 (BD); anti–Ly6C-FITC, AL-21 (BD); anti–IgM-FITC, II/41 
(BD);  anti–CD3e-FITC,  145-2C11  (BD);  anti–B220-PE,  RA3-6B2  (BD); 
anti–CD19-PE, 1D3 (BD); anti–NK1.1-PE, PK136 (BD); anti–CD49b-PE, 
DX5 (BD); anti–90.2-PE, 53–2.1 (BD); anti–Ly6G-PE, 1A8 (BD); anti–
Ter119-PE, TER-119  (BD);  anti–CD43-PE,  S7  (BD);  anti–GM-CSF-PE, 
MP1-22E9 (BD); anti–CD131-PE, JORO50 (BD); anti–IgG2A-PE, RTK2758 
(BD); anti–IgG1-PE, A85-1 (BD), anti–IgM-PerCPCy5.5, R6-60.2 (BD); 
anti–MHCII-PerCPCy5.5,  AF6-120.1  (BioLegend);  anti–CD11c-Per-
CPCy5.5, HL3 (BD); anti–CD8-PerCPCy5.5, 53–6.7 (BD); anti–IgG2A-
PerCP,  RTK2758  (BD);  anti–CD5-PECy7,  53–7.3  (eBioscience); 
anti–CD90.2-PECy7, 53–2.1 (BD); anti–CD45.1-PECy7, A20 (BD); anti–
F4/80-PECy7, BM8 (BioLegend); anti–IgM-APC, II/41 (BD); anti–CD43-
APC,  S7  (BD);  anti–BrdU-APC  (BD);  anti–Ly6C-APC, AL-21  (BD); 
anti–CD25-APC, PC61 (BD); anti–CD138-biotin, 281–2 (BD); anti–MHCII–
Alexa  Fluor  700,  M5/114.15.2  (eBioscience);  anti–CD4-Alexa  Fluor  700, 
GK1.5 (eBioscience); anti–CD19-APCCy7, 6D5 (BioLegend); anti–CD11b-
APCCy7,  M1/70  (BD);  anti–IgM-APCCy7,  RMM-1  (BioLegend);  anti–
CD45.2–Pacific blue (BD); anti–CD19-Brilliant  Violet 421, 6D5 (BioLegend); 
anti–IgM-Brilliant  Violet 421, RMM-1 (BioLegend); anti–CD11b-Brilliant  Vio-
let 421, M1/70 (BioLegend); and anti-CD93, AA4.1-FITC (BD). Streptavidin– 
Alexa Fluor 700 (Invitrogen) was used to label biotinylated antibodies. B cell 
populations  were  identified  as  described  previously  (Rauch  et  al.,  2012). 
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PE, BVD2-21C11 (BD); anti–CD20-PE-Cy7, L27 (BD); anti–IgM-PacBlue, 
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